Vasospastic Angina

• FDA approval · 2015-09-25
  FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)

  FDA approved a supplemental application for amlodipine besylate by PD-Rx Pharmaceuticals, Inc. under ANDA 076719, allowing marketing of this…

• FDA approval · 2015-09-17
  FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approves a supplemental application for AMLODIPINE BESYLATE from Aurobindo Pharma Limited under an ANDA.

• FDA approval · 2014-11-21
  FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for AMLODIPINE BESYLATE submitted by Zydus Pharmaceuticals USA Inc. under ANDA 078226.

• FDA approval · 2014-07-28
  FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)

  The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC.

• FDA approval · 2014-06-05
  FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved a supplemental application for Procardia XL (nifedipine) submitted by Pfizer Laboratories Div Pfizer Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2013-08-26
  FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved the supplemental application for amlodipine besylate from Lupin Pharmaceuticals, making its generic calcium channel blocker ava…

• FDA approval · 2013-01-07
  FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)

  The FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC. The approval is related to…

• FDA approval · 2011-08-19
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)

  FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride, allowing continued marketing of this generic p…

• FDA approval · 2010-04-09
  FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

  FDA approved Teva Pharmaceuticals' supplemental application for amlodipine besylate (generic). This action confirms the continued availabili…

• FDA approval · 2009-05-04
  FDA Approved: AMLODIPINE BESYLATE — Original Application (Ascend Laboratories, LLC)

  FDA approved Ascend Laboratories, LLC's original application for amlodipine besylate, a generic version, for indications including hypertens…

• FDA approval · 2008-02-19
  FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for amlodipine besylate by Zydus Pharmaceuticals USA Inc. under the ANDA framework. The action relat…

• FDA approval · 2007-07-17
  FDA Approved: AMLODIPINE BESYLATE — Original Application (Aurobindo Pharma Limited)

  FDA approves Aurobindo Pharma's amlodipine besylate as a generic product. It is indicated for hypertension and various forms of angina.

• FDA approval · 2007-07-11
  FDA Approved: AMLODIPINE BESYLATE — Original Application (ACI Healthcare USA, Inc.)

  FDA approved the original application for amlodipine besylate from ACI Healthcare USA, Inc., approving a generic version of this antihyperte…

• FDA approval · 2007-06-28
  FDA Approved: AMLODIPINE BESYLATE — Original Application (Teva Pharmaceuticals, Inc.)

  The FDA approved Teva Pharmaceuticals' amlodipine besylate as a generic product in an Original Application for indications including hyperte…

• FDA approval · 2007-05-11
  FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) from Actavis Pharma, Inc.